158 related articles for article (PubMed ID: 22593448)
1. Olfactory neuroblastoma: 15 years of experience.
Kondo N; Takahashi H; Nii Y; Nagao J
Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
[TBL] [Abstract][Full Text] [Related]
2. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
[TBL] [Abstract][Full Text] [Related]
4. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
5. Retained role of surgery for olfactory neuroblastoma.
Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
[TBL] [Abstract][Full Text] [Related]
6. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
[TBL] [Abstract][Full Text] [Related]
8. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
[TBL] [Abstract][Full Text] [Related]
9. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 34 cases of esthesioneuroblastoma].
Liu WS; Tang PZ; Xu GZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
15. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
[TBL] [Abstract][Full Text] [Related]
16. Esthesioneuroblastoma: 25-year experience at a single institution.
Zafereo ME; Fakhri S; Prayson R; Batra PS; Lee J; Lanza DC; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Apr; 138(4):452-8. PubMed ID: 18359353
[TBL] [Abstract][Full Text] [Related]
17. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
18. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
[TBL] [Abstract][Full Text] [Related]
20. Olfactory neuroblastoma in children: results of multimodality treatment in 2 patients.
Küpeli S; Yalçin B; Büyükpamukçu M
Pediatr Hematol Oncol; 2011 Feb; 28(1):56-9. PubMed ID: 21247350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
